High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

Clinical trial NCT00571584 · COMPLETED

Trial details

NCT number: NCT00571584
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A With Inhibitors Haemophilia B With Inhibitors

Start date: 2002-11-01
Primary completion: 2004-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.